Novel ultrasonic/magnetic resonance dual-mode contrast agent and preparation method and application thereof
A contrast agent and dual-mode technology, which is applied in the field of medical imaging, can solve the problems of little research on contrast agents and limit the development of multi-mode imaging technology, and achieve the effect of uniform shape, excellent stability and no pollution to the environment
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] Prepare 0.3 mg / mL DMSO solution of 2-phenylquinoline 3,3'-bipyridine dicarboxylate iridium complex and 0.3 mg / mL holmium acetate solution in DMSO for use. Take 2mL of the DMSO solution of the prepared 2-phenylquinoline 3,3'-bipyridinedicarboxylate iridium complex and place it in a single-necked flask, and add 10mg of polyvinylpyrrolidone (PVPK30), mix well, and raise the temperature to 50°C, keep the temperature constant for 0.1h, then take 2mL of the above-mentioned holmium acetate solution into the flask, and react for 0.25h. After the reaction, dialyze with deionized water for 12 hours, centrifuge and wash 3 times, disperse the obtained sample in deionized water, and perform ultrasonic and nuclear magnetic resonance tests.
[0042] figure 1 The scanning electron microscope spectrum of the dual-mode contrast agent prepared for this example, it can be seen from the figure that the contrast agent is spherical particles with good dispersibility and no agglomeration.
...
Embodiment 2
[0047] Prepare 0.5 mg / mL DMSO solution of 2-phenylquinoline 3,3'-bipyridyl dicarboxylate iridium complex and 0.7 mg / mL holmium acetate solution in DMSO for use. Take 2mL of the DMSO solution of the prepared 2-phenylquinoline 3,3'-bipyridinedicarboxylate iridium complex and place it in a single-necked flask, and add 20mg of polyvinylpyrrolidone (PVPK30), mix well, and raise the temperature to 70°C, keep the temperature constant for 0.2h, then take 2mL of the above-mentioned holmium acetate solution into the flask, and react for 0.5h. After the reaction, dialyze with deionized water for 12 hours, centrifuge and wash 3 times, disperse the obtained sample in deionized water, and perform ultrasonic and nuclear magnetic resonance tests.
Embodiment 3
[0049] Prepare 0.5 mg / mL DMSO solution of 2-phenylquinoline 3,3'-bipyridyl iridium complex and 0.9 mg / mL holmium acetate solution in DMSO for use. Take 5mL of the DMSO solution of the prepared 2-phenylquinoline 3,3'-bipyridinedicarboxylate iridium complex and place it in a single-necked flask, and add 30mg of polyvinylpyrrolidone (PVPK30), mix well, and raise the temperature to 70°C, keep the temperature constant for 0.3h, then take 2mL of the above-mentioned holmium acetate solution into the flask, and react for 1h. After the reaction, dialyze with deionized water for 12 hours, centrifuge and wash 3 times, disperse the obtained sample in deionized water, and perform ultrasonic and nuclear magnetic resonance tests.
PUM
Property | Measurement | Unit |
---|---|---|
thickness | aaaaa | aaaaa |
particle diameter | aaaaa | aaaaa |
thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com